Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lisaftoclax”

21 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 21 results

Early research (Phase 1)WithdrawnNCT07428486
What this trial is testing

FLAG Chemotherapy In Combination With Lisaftoclax And Pelcitoclax In Patients With Relapsed/Refractory T-Cell Acute Lymphoblastic Leukemia

Who this might be right for
Phase IFLAG ChemotherapyLisaftoclax+3 more
M.D. Anderson Cancer Center
Testing effectiveness (Phase 2)Looking for participantsNCT04501120
What this trial is testing

Study of Lisaftoclax (APG-2575) Single Agent and Combination With Therapy in Patients Relapsed/Refractory AML

Who this might be right for
Relapsed/Refractory Acute Myeloid LeukaemiaMyeloid Malignancy
Ascentage Pharma Group Inc. 682
Testing effectiveness (Phase 2)Looking for participantsNCT05147467
What this trial is testing

Study of APG-2575 in Patients With Relapsed/Refractory CLL/SLL

Who this might be right for
Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma
Ascentage Pharma Group Inc. 75
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07831395
What this trial is testing

Rituximab, Pirtobrutinib, Lisaftoclax and Liposomal Mitoxantrone for for Richter Syndrome Transformed From CLL

Who this might be right for
Richter Syndrome
Institute of Hematology & Blood Diseases Hospital, China 23
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07684950
What this trial is testing

Lisaftoclax Plus Pirtobrutinib in Relapsed or Refractory Mantle Cell Lymphoma After BTK-Targeted Therapy

Who this might be right for
Mantle Cell Lymphoma (MCL)
Henan Cancer Hospital 45
Testing effectiveness (Phase 2)Looking for participantsNCT07272499
What this trial is testing

Orelabrutinib Plus Lisaftoclax and Rituximab in Untreated Mantle Cell Lymphoma With High-Risk Disease

Who this might be right for
Mantle Cell Lymphoma (MCL)
Ruijin Hospital 25
Large-scale testing (Phase 3)Looking for participantsNCT06641414
What this trial is testing

Lisaftoclax (APG-2575) Combined With Azacytidine (AZA) in the Treatment of Patients With Higher-risk Myelodysplastic Syndrome (GLORA-4).

Who this might be right for
Higher-risk Myelodysplastic Syndrome
Ascentage Pharma Group Inc. 490
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07459608
What this trial is testing

Efficacy and Safety of Lisaftoclax (APG-2575) Monotherapy in Patients With Mature B-cell Lymphoma

Who this might be right for
Indolent LymphomaWMMZL+1 more
Henan Cancer Hospital 75
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07601607
What this trial is testing

Lisaftoclax Plus Chidamide and Rituximab in Relapsed or Refractory Diffuse Large B-cell Lymphoma

Who this might be right for
Relapsed or Refractory Diffuse Large B-Cell Lymphoma (R/R DLBCL)
Sun Yat-sen University 51
Large-scale testing (Phase 3)Looking for participantsNCT06104566
What this trial is testing

Global Trial in APG2575 for Patients With CLL/SLL

Who this might be right for
CLL/SLL
Ascentage Pharma Group Inc. 400
Large-scale testing (Phase 3)Not Yet RecruitingNCT07686965
What this trial is testing

Lisaftoclax Plus Azacitidine Maintenance After Allogeneic Hematopoietic Stem Cell Transplantation in Acute Myeloid Leukemia Patients at High Risk of Relapse

Who this might be right for
Acute Myeloid Leukemia (AML)Maintenance TreatmentHematopoetic Stem Cell Transplantation
Institute of Hematology & Blood Diseases Hospital, China 191
Large-scale testing (Phase 3)Not Yet RecruitingNCT07597941
What this trial is testing

Lisaftoclax for Prevention of Differentiation Syndrom in Acute Promyelocytic Leukemia Patients

Who this might be right for
Acute Promyelocytic Leukemia (APL)
The Affiliated People's Hospital of Ningbo University 20
Large-scale testing (Phase 3)Looking for participantsNCT06389292
What this trial is testing

A Pivotal Study of APG-2575 (Lisaftoclax) Combined With Azacitidine in the Treatment of Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
Ascentage Pharma Group Inc. 486
Early research (Phase 1)Looking for participantsNCT06401603
What this trial is testing

A Phase I Study of Decitabine, Lisaftoclax, and Olverembatinib in Patients With Advanced Chronic Myeloid Leukemia and Philadelphia Chromosome-Positive Acute Myeloid Leukemia

Who this might be right for
Advanced Chronic Myeloid LeukemiaPhiladelphia Chromosome-Positive Acute Myeloid Leukemia
M.D. Anderson Cancer Center 30
Large-scale testing (Phase 3)Enrolling By InvitationNCT07651176
What this trial is testing

Comparing the Efficacy of the LDA, LHAA, and DA Regimens in Young Adults With Low-Risk Acute Myeloid Leukemia Eligible for Intensive Chemotherapy

Who this might be right for
Acute Myeloid LeukemiaLisaftoclax
First Affiliated Hospital of Zhejiang University 267
Large-scale testing (Phase 3)Looking for participantsNCT06319456
What this trial is testing

Lisaftoclax (APG-2575) Combined With Acalabrutinib Versus Immunochemotherapy for Newly Diagnosed CLL/SLL.

Who this might be right for
CLL/SLL
Ascentage Pharma Group Inc. 344
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07552324
What this trial is testing

Study on the Treatment of Double/Triple-hit DLBCL With Chidamide and Lisaftoclax in Combination With Pola-R-CHP

Who this might be right for
DHLTHLDLBCL - Diffuse Large B Cell Lymphoma
Ruijin Hospital 28
Testing effectiveness (Phase 2)Enrolling By InvitationNCT07813390
What this trial is testing

Homoharringtonine, Lisaftoclax, and Azacitidine for AML After Venetoclax-Based Therapy Failure

Who this might be right for
Acute Myeloid Leukemia (AML)
Guangdong Second Provincial General Hospital 73
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07717580
What this trial is testing

Efficacy and Safety of Brentuximab Vedotin Combined With Lisaftoclax in CD30+ Cutaneous T-cell Lymphoma (CTCL)

Who this might be right for
Cutaneous T-Cell Lymphoma/Mycosis FungoidesPrimary Cutaneous Anaplastic Large Cell Lymphoma
Peking University First Hospital 46
Testing effectiveness (Phase 2)Looking for participantsNCT07255963
What this trial is testing

Pirtobrutinib, Lisaftoclax, and Rituximab in the Treatment of R/R DLBCL

Who this might be right for
DLBCL - Diffuse Large B Cell Lymphoma
The First Affiliated Hospital of Soochow University 29
Next Page